Predictive Markers of High-Grade or Serious Treatment-Emergent Infections with Daratumumab-Based Regimens in Newly Diagnosed Multiple Myeloma (NDMM)
Authors:
Open Access
- 5 November 2020
- journal article
- abstracts
- Published by American Society of Hematology in Blood
- Vol. 136 (Supplement) , 10-11